(±)-Zanubrutinib

Overview

(±)-Zanubrutinib ((±)-BGB-3111) is the racemate of Zanubrutinib ( HY-101474A ). (±)-Zanubrutinib inhibits Bruton's tyrosine kinase ( Btk ) with an IC 50 of 0.63 nM.

Application

Products | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Btk

Product Information

• Catalog No.: HY-101474
• CAS No.: 1633350-06-7
• Molecular Formula: C27H29N5O3
• Molecular Weight: 471.55
• Purity: 99.41%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (4.41 mM); Clear solution
• Availability: In-stock

Source

Original product source